{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:47:17Z","timestamp":1792691237902,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:00:00Z","timestamp":1494633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:00:00Z","timestamp":1494633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-11-2-0135"],"award-info":[{"award-number":["W81XWH-11-2-0135"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10549-017-4291-8","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T07:26:19Z","timestamp":1494660379000},"page":"593-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer"],"prefix":"10.1007","volume":"164","author":[{"given":"Seth K.","family":"Rummel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leann","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,13]]},"reference":[{"key":"4291_CR1","volume-title":"Breast cancer facts & figures\u00a02015-2016","author":"American Cancer Society","year":"2015","unstructured":"American Cancer Society (2015) Breast cancer facts & figures\u00a02015-2016. American Cancer Society Inc, Atlanta"},{"issue":"22","key":"4291_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/jnci\/djn344","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643\u20131648. doi:\n                    10.1093\/jnci\/djn344","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4291_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A (2009) Elevated breast cancer mortality in women younger than age 40\u00a0years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208(3):341\u2013347","journal-title":"J Am Coll Surg"},{"issue":"5","key":"4291_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1200\/JCO.1994.12.5.888","volume":"12","author":"AJ Nixon","year":"1994","unstructured":"Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12(5):888\u2013894","journal-title":"J Clin Oncol"},{"issue":"2","key":"4291_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1023006000760","volume":"14","author":"MD Althuis","year":"2003","unstructured":"Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA (2003) Breast cancers among very young premenopausal women (United States). Cancer Causes Control 14(2):151\u2013160","journal-title":"Cancer Causes Control"},{"issue":"1","key":"4291_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13058-016-0736-y","volume":"18","author":"L Chollet-Hinton","year":"2016","unstructured":"Chollet-Hinton L, Anders CK, Tse CK, Bell MB, Yang YC, Carey LA, Olshan AF, Troester MA (2016) Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study. Breast Cancer Res 18(1):79. doi:\n                    10.1186\/s13058-016-0736-y","journal-title":"Breast Cancer Res"},{"issue":"6","key":"4291_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.clbc.2014.06.002","volume":"14","author":"H Gewefel","year":"2014","unstructured":"Gewefel H, Salhia B (2014) Breast cancer in adolescent and young adult women. Clin Breast Cancer 14(6):390\u2013395. doi:\n                    10.1016\/j.clbc.2014.06.002","journal-title":"Clin Breast Cancer"},{"key":"4291_CR8","unstructured":"National Comprehensive Cancer Network (2016) Genetic\/familial high-risk assessment: breast and ovarian cancer, vol 2.2017. National Comprehensive Cancer Network, Fort Washington, PA."},{"issue":"2","key":"4291_CR9","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/bcr3172","volume":"14","author":"DS Lee","year":"2012","unstructured":"Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH (2012) Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1\/2 screening to early-onset breast cancer patients. Breast Cancer Res 14(2):R66. doi:\n                    10.1186\/bcr3172","journal-title":"Breast Cancer Res"},{"key":"4291_CR10","unstructured":"National Comprehensive Cancer Network (2016) Breast cancer risk reduction. 1.2017 edn. National Comprehensive Cancer Network, Fort Washington, PA."},{"key":"4291_CR11","unstructured":"American Joint Committee on Cancer (2010) AJCC cancer staging manual, vol 7th. Springer, New York"},{"issue":"3","key":"4291_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/bjc.1957.43","volume":"11","author":"HJ Bloom","year":"1957","unstructured":"Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3):359\u2013377","journal-title":"Br J Cancer"},{"issue":"5","key":"4291_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403\u2013410","journal-title":"Histopathology"},{"issue":"16","key":"4291_CR14","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FCG, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795","journal-title":"J Clin Oncol"},{"key":"4291_CR15","doi-asserted-by":"crossref","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF, American Society of Clinical O, College of American P (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013. doi:10.1200\/JCO.2013.50.9984","DOI":"10.1200\/JCO.2013.50.9984"},{"key":"4291_CR16","doi-asserted-by":"publisher","unstructured":"Carraro DM, Koike Folgueira MA, Garcia Lisboa BC, Olivieri EHR, Krepischi ACV, de Carvalho AF, de Carvalho Mota LD, Puga RD, do Socorro Maciel M, Michelli RA, de Lyra EC, Grosso SH, Soares FA, Achatz MI, Brentani H, Moreira-Filho CA, Brentani MM (2013) Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS One 8(3):e57581. doi:\n                    10.1371\/journal.pone.0057581","DOI":"10.1371\/journal.pone.0057581"},{"issue":"4","key":"4291_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ijc.11271","volume":"106","author":"S de Sanjose","year":"2003","unstructured":"de Sanjose S, Leone M, Berez V, Izquierdo A, Font R, Brunet JM, Louat T, Vilardell L, Borras J, Viladiu P, Bosch FX, Lenoir GM, Sinilnikova OM (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 106(4):588\u2013593. doi:\n                    10.1002\/ijc.11271","journal-title":"Int J Cancer"},{"issue":"3","key":"4291_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","volume":"16","author":"A Musolino","year":"2007","unstructured":"Musolino A, Bella MA, Bortesi B, Michiara M, Naldi N, Zanelli P, Capelletti M, Pezzuolo D, Camisa R, Savi M, Neri TM, Ardizzoni A (2007) BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. Breast 16(3):280\u2013292. doi:\n                    10.1016\/j.breast.2006.12.003","journal-title":"Breast"},{"issue":"4","key":"4291_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.1626","volume":"97","author":"A Meindl","year":"2002","unstructured":"Meindl A, German Consortium for Hereditary B, Ovarian C (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97(4):472\u2013480","journal-title":"Int J Cancer"},{"issue":"3","key":"4291_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/1097-0215(20010520)95:3<189::AID-IJC1032>3.0.CO;2-N","volume":"95","author":"PN Tonin","year":"2001","unstructured":"Tonin PN, Perret C, Lambert JA, Paradis AJ, Kantemiroff T, Benoit MH, Martin G, Foulkes WD, Ghadirian P (2001) Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history. Int J Cancer 95(3):189\u2013193","journal-title":"Int J Cancer"},{"issue":"6","key":"4291_CR21","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P","volume":"88","author":"KE Malone","year":"2000","unstructured":"Malone KE, Daling JR, Neal C, Suter NM, O\u2019Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA (2000) Frequency of BRCA1\/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88(6):1393\u20131402","journal-title":"Cancer"},{"issue":"3","key":"4291_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM199601183340301","volume":"334","author":"AA Langston","year":"1996","unstructured":"Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334(3):137\u2013142. doi:\n                    10.1056\/NEJM199601183340301","journal-title":"N Engl J Med"},{"issue":"3","key":"4291_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199601183340302","volume":"334","author":"MG FitzGerald","year":"1996","unstructured":"FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O\u2019Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334(3):143\u2013149. doi:\n                    10.1056\/NEJM199601183340302","journal-title":"N Engl J Med"},{"issue":"16","key":"4291_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215\u20131223","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"4291_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman AR, Winer EP, Garber JE (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34(13):1460\u20131468. doi:\n                    10.1200\/JCO.2015.65.0747","journal-title":"J Clin Oncol"},{"issue":"4","key":"4291_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L, Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C, Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33(4):304\u2013311. doi:\n                    10.1200\/JCO.2014.57.1414","journal-title":"J Clin Oncol"},{"issue":"1","key":"4291_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-014-3195-0","volume":"149","author":"JE Churpek","year":"2015","unstructured":"Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, Lee MK, Casadei S, Watts A, Neistadt B, Churpek MM, Huo D, Zvosec C, Liu F, Niu Q, Marquez R, Zhang J, Fackenthal J, King MC, Olopade OI (2015) Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat 149(1):31\u201339. doi:\n                    10.1007\/s10549-014-3195-0","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4291_CR28","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.18632\/oncotarget.7027","volume":"7","author":"PH Lin","year":"2016","unstructured":"Lin PH, Kuo WH, Huang AC, Lu YS, Lin CH, Kuo SH, Wang MY, Liu CY, Cheng FT, Yeh MH, Li HY, Yang YH, Hsu YH, Fan SC, Li LY, Yu SL, Chang KJ, Chen PL, Ni YH, Huang CS (2016) Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget 7(7):8310\u20138320. doi:\n                    10.18632\/oncotarget.7027","journal-title":"Oncotarget"},{"issue":"1","key":"4291_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13058-016-0758-5","volume":"18","author":"TA Muranen","year":"2016","unstructured":"Muranen TA, Blomqvist C, Dork T, Jakubowska A, Heikkila P, Fagerholm R, Greco D, Aittomaki K, Bojesen SE, Shah M, Dunning AM, Rhenius V, Hall P, Czene K, Brand JS, Darabi H, Chang-Claude J, Rudolph A, Nordestgaard BG, Couch FJ, Hart SN, Figueroa J, Garcia-Closas M, Fasching PA, Beckmann MW, Li J, Liu J, Andrulis IL, Winqvist R, Pylkas K, Mannermaa A, Kataja V, Lindblom A, Margolin S, Lubinski J, Dubrowinskaja N, Bolla MK, Dennis J, Michailidou K, Wang Q, Easton DF, Pharoah PD, Schmidt MK, Nevanlinna H (2016) Patient survival and tumor characteristics associated with CHEK2:p.I157T\u2014findings from the Breast Cancer Association Consortium. Breast Cancer Res 18(1):98. doi:\n                    10.1186\/s13058-016-0758-5","journal-title":"Breast Cancer Res"},{"issue":"19","key":"4291_CR30","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE, Cargill M, Ford JM (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32(19):2001\u20132009. doi:\n                    10.1200\/JCO.2013.53.6607","journal-title":"J Clin Oncol"},{"issue":"17","key":"4291_CR31","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1158\/0008-5472.CAN-08-0599","volume":"68","author":"MD Palma","year":"2008","unstructured":"Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68(17):7006\u20137014. doi:\n                    10.1158\/0008-5472.CAN-08-0599","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4291-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4291-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4291-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:57:43Z","timestamp":1589720263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4291-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,13]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4291-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,13]]},"assertion":[{"value":"11 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}